US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Concho Resources

65.60

0.0000

Volume:- -

Turnover:- -

Market Cap:12.76B

PE:-1.26

High:65.60

Open:65.60

Low:65.60

Close:65.60

52wk High:90.52

52wk Low:33.13

Shares:194.51M

Float Shares:192.49M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.73

Dividend Rate:1.11%

EPS(TTM):-52.2669

EPS(LYR):-3.5480

ROE:-77.91%

ROA:-30.69%

PB:1.64

PE(LYR):-18.49

Loading ...

Overview Company News Filings

Zeon Overhauls Governance With New CXO Management Structure

Brain-Computer Interface, AI Healthcare, and CXO Sectors Thrive! Strategic Entry into Low-Position HUAXIA CSI HONG KONG STOCK CONNECT MEDICAL THEME ETF (159137) May Be Timely

Guosen Securities: Small Nucleic Acid CXO Sector Sees Sustained Growth Momentum, Entering Clinical Validation and Commercial Acceleration Phase

Chen Guo: Spring Rally Not Over Yet, How Will Market Structure Shift?

Guolian Minsheng Securities: Global CXO Industry Shows Strong Recovery, High Growth Momentum Expected to Continue Through 2026

Is Core Lithium’s (ASX:CXO) Lithium Price Sensitivity a Strategic Edge or a Structural Vulnerability?

Simply Wall St.

Core Lithium (ASX:CXO) Valuation Check After One Of The Largest Recent Share Price Drops On The ASX

Simply Wall St.

Southwest Securities: CXO Industry Focuses on New Molecule Growth and Domestic Recovery Momentum

Zhytong Hong Kong Market Analysis | Geopolitical Concerns Drive Many Gold Stocks to Record Highs; Positive News Boosts CXO Sector

Is Core Lithium’s (ASX:CXO) Cautious Finniss Restart Plan Redefining Its Capital Discipline Story?

Simply Wall St.

Guosen Securities: New U.S. Pharmaceutical Supply Chain Regulations Highlight Investment Opportunities in CXO Sector

CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2

One-Click Access to Innovative Drugs and CXO Core Sectors: Hang Seng Biotech ETF by Fullgoal Fund Set to Launch

Hong Kong Stock Concept Tracking | Strong Performance Growth in Innovative Drug Sector, Upstream CXO Industry Adjustments Largely Completed (With Concept Stocks)

China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs

Haina Pharma's Shift to Hong Kong IPO: CXO Dependence, Cash Flow Woes, and Volatile Major Clients

Core Lithium (ASX:CXO): Assessing Valuation After Finniss Project Overhaul and Upgraded Ore Reserves

Simply Wall St.

Why Core Lithium (ASX:CXO) Is Up 26.7% After Upgrading Finniss Ore Reserves and Cutting Costs

Simply Wall St.

IPO Preview: Can Haina Pharma's "CXO + Proprietary Pipeline" Model Shine in Hong Kong?

Haina Pharma's HK IPO: Declining Revenue & Net Profit in H1, Heavy Reliance on CXO Services Raises Sustainability Concerns

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CXO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"Concho Resources","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"Delisted","change":0,"latestTime":"01-15 16:00:00 EST","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.255097,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[],"updateTime":1770563340769},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609466565","title":"Zeon Overhauls Governance With New CXO Management Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2609466565","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609466565?lang=en_us&edition=fundamental","pubTime":"2026-02-06 16:53","pubTimestamp":1770368014,"startTime":"0","endTime":"0","summary":"An update from Zeon ( ($JP:4205) ) is now available. Zeon Corporation has announced it will abolish its traditional headquarters structure and intr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zeon-overhauls-governance-with-new-cxo-management-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zeon-overhauls-governance-with-new-cxo-management-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CXO"],"gpt_icon":0},{"id":"1123166875","title":"Brain-Computer Interface, AI Healthcare, and CXO Sectors Thrive! Strategic Entry into Low-Position HUAXIA CSI HONG KONG STOCK CONNECT MEDICAL THEME ETF (159137) May Be Timely","url":"https://stock-news.laohu8.com/highlight/detail?id=1123166875","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123166875?lang=en_us&edition=fundamental","pubTime":"2026-02-03 14:11","pubTimestamp":1770099103,"startTime":"0","endTime":"0","summary":"A bullish MACD golden cross signal has formed, indicating a positive trend for these stocks!","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159137","520510","CXO","159891"],"gpt_icon":0},{"id":"1195128303","title":"Guosen Securities: Small Nucleic Acid CXO Sector Sees Sustained Growth Momentum, Entering Clinical Validation and Commercial Acceleration Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1195128303","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195128303?lang=en_us&edition=fundamental","pubTime":"2026-02-02 14:36","pubTimestamp":1770014188,"startTime":"0","endTime":"0","summary":"Small nucleic acid CXO, serving as the core support for the small nucleic acid drug industry, is benefiting from technological breakthroughs and accelerated commercialization, leading to a continuous...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0276","BK0028","CXO","002736","BK0188"],"gpt_icon":0},{"id":"1125456654","title":"Chen Guo: Spring Rally Not Over Yet, How Will Market Structure Shift?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125456654","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125456654?lang=en_us&edition=fundamental","pubTime":"2026-02-01 22:42","pubTimestamp":1769956953,"startTime":"0","endTime":"0","summary":"Investing in stocks requires reading the research reports of Golden麒麟 analysts, which are authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities!...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","BK4211","PCB"],"gpt_icon":0},{"id":"1104127218","title":"Guolian Minsheng Securities: Global CXO Industry Shows Strong Recovery, High Growth Momentum Expected to Continue Through 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1104127218","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104127218?lang=en_us&edition=fundamental","pubTime":"2026-01-28 16:10","pubTimestamp":1769587852,"startTime":"0","endTime":"0","summary":"Guolian Minsheng Securities released a research report stating that global biotech and pharmaceutical company investment and financing activities, along with transaction demand, have significantly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01456","BK1564","BK1147","CXO","601456","BK0276","161027"],"gpt_icon":0},{"id":"2606316092","title":"Is Core Lithium’s (ASX:CXO) Lithium Price Sensitivity a Strategic Edge or a Structural Vulnerability?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606316092","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606316092?lang=en_us&edition=fundamental","pubTime":"2026-01-24 17:32","pubTimestamp":1769247162,"startTime":"0","endTime":"0","summary":"Core Lithium recently experienced a sharp pullback as falling lithium prices and technical selling pressure weighed on sentiment toward its near-term earnings and cost profile.\nThe episode highlights how tightly Core Lithium’s market perception is linked to movements in Chinese lithium carbonate prices and short-term trading flows.\nWe’ll now examine how this link between Core Lithium’s outlook and lithium price volatility shapes the company’s broader investment narrative.\nThis technology...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/is-core-lithiums-asxcxo-lithium-price-sensitivity-a-strategi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/is-core-lithiums-asxcxo-lithium-price-sensitivity-a-strategi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","PLS.AU","CXO.AU","BK7507","CXO","BK7504"],"gpt_icon":0},{"id":"2605413886","title":"Core Lithium (ASX:CXO) Valuation Check After One Of The Largest Recent Share Price Drops On The ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2605413886","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605413886?lang=en_us&edition=fundamental","pubTime":"2026-01-22 18:35","pubTimestamp":1769078137,"startTime":"0","endTime":"0","summary":"What triggered the latest move in Core Lithium shares?\nCore Lithium (ASX:CXO) has drawn attention after a near 10% share price drop, one of the largest moves on the ASX. Weaker lithium prices and technical selling pressure contributed to the decline amid broader market volatility.\nSee our latest analysis for Core Lithium.\nDespite the latest drop, Core Lithium’s recent 90 day share price return of 176.19% and 1 year total shareholder return of 190% show strong past momentum. However, the 3...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-valuation-check-after-one-of-the-largest","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-valuation-check-after-one-of-the-largest","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK7504","CXO.AU","CXO","BK7095"],"gpt_icon":0},{"id":"1185501099","title":"Southwest Securities: CXO Industry Focuses on New Molecule Growth and Domestic Recovery Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1185501099","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185501099?lang=en_us&edition=fundamental","pubTime":"2026-01-16 11:04","pubTimestamp":1768532686,"startTime":"0","endTime":"0","summary":"Southwest Securities released a research report stating that the CXO sector warrants continuous attention on: 1) the growth momentum continuously injected into R, D, and M outsourcing by new...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0188","BK0028","600369","BK0276","BK0012","CXO"],"gpt_icon":0},{"id":"1178103940","title":"Zhytong Hong Kong Market Analysis | Geopolitical Concerns Drive Many Gold Stocks to Record Highs; Positive News Boosts CXO Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1178103940","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178103940?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:51","pubTimestamp":1768308689,"startTime":"0","endTime":"0","summary":"The continuously rising A-share market finally experienced a correction, while the Hong Kong market showed strong catch-up momentum today, opening with a gap up. However, after approaching the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0dd7376a2fff8e681d2b5cc4f4f27b72","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ62798434.SGD","01072","LU2125910500.SGD","02315","LU2242644610.SGD","00100","BK1576","BK1161","BK1583","BK1522","02259","BK1198","LU2213484517.USD","BK1546","HK0000500386.USD","LU0320764599.SGD","BK1141","LU1046422090.SGD","LU0593848301.USD","BK1117","BK1205","HK0000252160.HKD","LU2543165471.USD","LU0708995583.HKD","02513","LU0052750758.USD","CXO","LU2045819591.USD","159562","02359","SGXZ86797644.SGD","HK0000252152.HKD"],"gpt_icon":1},{"id":"2602306650","title":"Is Core Lithium’s (ASX:CXO) Cautious Finniss Restart Plan Redefining Its Capital Discipline Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602306650","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602306650?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:17","pubTimestamp":1767964658,"startTime":"0","endTime":"0","summary":"In early January 2026, Core Lithium outlined a cautious restart stance for its Finniss Lithium Project as lithium prices and interest in battery metals rebounded after a prolonged downturn.\nThe company’s focus on capital discipline, cost control, and aligning any restart with more sustainable lithium pricing has become a central theme for how investors assess its prospects.\nWith lithium prices rebounding and Core Lithium prioritising a disciplined Finniss restart, we’ll examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/is-core-lithiums-asxcxo-cautious-finniss-restart-plan-redefi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/is-core-lithiums-asxcxo-cautious-finniss-restart-plan-redefi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CXO.AU","CXO","BK7095","BK7507","BK7504","PLS.AU"],"gpt_icon":0},{"id":"1194030810","title":"Guosen Securities: New U.S. Pharmaceutical Supply Chain Regulations Highlight Investment Opportunities in CXO Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1194030810","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194030810?lang=en_us&edition=fundamental","pubTime":"2025-12-25 10:06","pubTimestamp":1766628378,"startTime":"0","endTime":"0","summary":"Guosen Securities released a research report stating that the U.S. Congress recently passed the fiscal year 2026 National Defense Authorization Act (2026 NDAA), which includes revised provisions of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0276","BK1161","09939","BK0188","159938","BK1515","CXO","002736","BK0183","BK0028"],"gpt_icon":0},{"id":"1120480059","title":"CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2","url":"https://stock-news.laohu8.com/highlight/detail?id=1120480059","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120480059?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:14","pubTimestamp":1765246458,"startTime":"0","endTime":"0","summary":"CMB International released a research report stating that the 2025 edition of China's basic medical insurance catalog and the first commercial insurance catalog have been announced, continuing to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828714.EUR","BK1161","IE00BZ08YS42.EUR","02367","01801","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","02273","BK1219","BK1593","LU1969619763.USD","LU2328871848.SGD","BK1207","LU2488822045.USD","BK1521","HK0000165453.HKD","BK1589","LU2097828805.USD","BK1515","BK1191","SG9999004311.SGD","LU0502904849.HKD","02268","BK1141","LU2097828557.USD","01530","CXO","LU2097828474.EUR","01177","BK1583","SG9999014674.SGD","LU0455707207.USD","LU2097828631.EUR","LU2242644610.SGD"],"gpt_icon":0},{"id":"1172331639","title":"One-Click Access to Innovative Drugs and CXO Core Sectors: Hang Seng Biotech ETF by Fullgoal Fund Set to Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1172331639","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172331639?lang=en_us&edition=fundamental","pubTime":"2025-11-28 14:41","pubTimestamp":1764312104,"startTime":"0","endTime":"0","summary":"This year, the Hong Kong stock market's healthcare sector has consistently captured market attention. According to Wind data, as of November 24, southbound capital recorded a net inflow of over HKD...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","513280","06978","CXO","BK1161"],"gpt_icon":0},{"id":"1179782588","title":"Hong Kong Stock Concept Tracking | Strong Performance Growth in Innovative Drug Sector, Upstream CXO Industry Adjustments Largely Completed (With Concept Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1179782588","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179782588?lang=en_us&edition=fundamental","pubTime":"2025-11-24 08:24","pubTimestamp":1763943884,"startTime":"0","endTime":"0","summary":"Wind data shows that among 29 listed companies in the A-share CXO sector, 20 reported year-on-year revenue growth for the first three quarters. The performance of innovative drug companies has been...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1610","02359","LU1688375341.USD","LU0051755006.USD","LU0708995583.HKD","LU1242518857.USD","BK1521","LU0326950275.SGD","LU0327786744.USD","LU0348735423.USD","BK1141","LU2125910500.SGD","LU0039217434.USD","LU0516422440.USD","LU0417516902.SGD","LU0588546209.SGD","LU1046422090.SGD","LU1880383366.USD","LU0516423091.SGD","SG9999002463.SGD","06821","LU0456827905.SGD","LU0516422366.SGD","LU1242518931.SGD","LU0516422952.EUR","06978","BK1576","LU0043850808.USD","LU0979878070.USD","BK1583","LU0359202008.SGD","LU0417516738.SGD","LU0348825331.USD","159992","LU0320764599.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0140636845.USD","BK1161","LU0823426308.USD","LU0456846285.SGD","LU1720050803.USD","LU2039709279.SGD","LU0181495838.USD","LU2242644610.SGD","LU1794554557.SGD","LU0819121731.USD","LU0052750758.USD","BK1191","BK1589","LU0307460666.USD","LU0359201612.USD","LU0516423174.USD","LU2045819591.USD","SG9999002562.SGD","CXO","02269","LU0823426480.USD","LU3063872942.SGD","LU0856984785.SGD"],"gpt_icon":0},{"id":"1118534015","title":"China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs","url":"https://stock-news.laohu8.com/highlight/detail?id=1118534015","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118534015?lang=en_us&edition=fundamental","pubTime":"2025-11-24 07:42","pubTimestamp":1763941341,"startTime":"0","endTime":"0","summary":"According to a research report by China Securities Co., Ltd., the innovative drug sector exhibits three major trends: deepening internationalization (2.0 phase), with 2025 license-out deals reaching...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","BK0276","CDMO","BK4139","601066"],"gpt_icon":0},{"id":"1116189617","title":"Haina Pharma's Shift to Hong Kong IPO: CXO Dependence, Cash Flow Woes, and Volatile Major Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=1116189617","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116189617?lang=en_us&edition=fundamental","pubTime":"2025-11-23 16:40","pubTimestamp":1763887244,"startTime":"0","endTime":"0","summary":"After failing in its attempt to list on the ChiNext board and an unsuccessful acquisition by Chengdu Pioneer (688222.SH), Nanjing Haina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","159938","CXO","BK1515","09939","159399"],"gpt_icon":0},{"id":"2583638001","title":"Core Lithium (ASX:CXO): Assessing Valuation After Finniss Project Overhaul and Upgraded Ore Reserves","url":"https://stock-news.laohu8.com/highlight/detail?id=2583638001","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583638001?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:39","pubTimestamp":1763156368,"startTime":"0","endTime":"0","summary":"Core Lithium (ASX:CXO) climbed to a 52-week high after announcing a revised reopening plan for its Finniss Project. The new plan lowers pre-production costs and increases the Grants deposit ore reserve estimate by 33%.\nSee our latest analysis for Core Lithium.\nThis rally caps off a stunning stretch for Core Lithium, with a 1-day share price return of 5.26% and 37.93% over the past week. This reflects renewed investor confidence after the Finniss Project update. Momentum has accelerated...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-assessing-valuation-after-finniss-projec","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-assessing-valuation-after-finniss-projec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PLS.AU","CXO.AU","CXO"],"gpt_icon":0},{"id":"2583561324","title":"Why Core Lithium (ASX:CXO) Is Up 26.7% After Upgrading Finniss Ore Reserves and Cutting Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583561324","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583561324?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:20","pubTimestamp":1763025616,"startTime":"0","endTime":"0","summary":"Core Lithium recently announced an updated reopening plan for the Finniss Project, deferring the transition to underground mining and cutting pre-production costs by A$35 million to A$45 million, while also increasing the ore reserve estimate for the Grants deposit by 33%.\nThis development enhances the project's appeal for funding partners and aligns with stronger global demand for battery-grade lithium, supported by recent strength in lithium prices.\nWe'll explore how the ore reserve...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-267-after-upgrading-finniss-or","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-267-after-upgrading-finniss-or","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7504","AI","CXO.AU","CXO","BK7095","PLS.AU","BK7507"],"gpt_icon":0},{"id":"1173746546","title":"IPO Preview: Can Haina Pharma's \"CXO + Proprietary Pipeline\" Model Shine in Hong Kong?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173746546","media":"Stock News","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173746546?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022626,"startTime":"0","endTime":"0","summary":"Nanjing Haina Pharmaceutical Technology Co., Ltd. (Haina Pharma) has submitted its IPO application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as its sole...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","CXO","BK1574","BK1161","159938"],"gpt_icon":0},{"id":"1116581182","title":"Haina Pharma's HK IPO: Declining Revenue & Net Profit in H1, Heavy Reliance on CXO Services Raises Sustainability Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1116581182","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116581182?lang=en_us&edition=fundamental","pubTime":"2025-11-12 16:11","pubTimestamp":1762935065,"startTime":"0","endTime":"0","summary":"Nanjing Haina Pharmaceutical Technology Co., Ltd. officially submitted its main board listing application to the Hong Kong Stock Exchange on November 7, 2025. This marks the company's third attempt...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","159776"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}